메뉴 건너뛰기




Volumn 39, Issue 3, 2011, Pages 529-542

Gene expression profiles predicting the response to IFN-β and a combination of temozolomide and IFN-β in malignant gliomas

Author keywords

Chemotherapy; Interferon ; Malignant glioma; Synergistic effect; Temozolomide

Indexed keywords

BETA INTERFERON; BIOLOGICAL MARKER; TEMOZOLOMIDE;

EID: 79959955164     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1068     Document Type: Article
Times cited : (10)

References (46)
  • 1
    • 65349121788 scopus 로고    scopus 로고
    • Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase III study: 5-year analysis of the EORTC-NCIC trial
    • Stupp R, Hegi ME, Mason WP, et al: Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10: 459-466, 2009.
    • (2009) Lancet Oncol , vol.10 , pp. 459-466
    • Stupp, R.1    Hegi, M.E.2    Mason, W.P.3
  • 2
    • 0025195404 scopus 로고
    • 6-alkylguanine-DNA alkyltransferase: Regulation and importance in response to alkylating carcinogenic and therapeutic agents
    • 6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res 50: 6119-6129, 1990.
    • (1990) Cancer Res , vol.50 , pp. 6119-6129
    • Pegg, A.E.1
  • 3
    • 77951580527 scopus 로고    scopus 로고
    • Gene expression profiling predicts response to temozolomide in malignant gliomas
    • Yoshino A, Ogino A, Yachi K, et al: Gene expression profiling predicts response to temozolomide in malignant gliomas. Int J Oncol 36: 1367-1377, 2010.
    • (2010) Int J Oncol , vol.36 , pp. 1367-1377
    • Yoshino, A.1    Ogino, A.2    Yachi, K.3
  • 4
    • 2942726249 scopus 로고    scopus 로고
    • Two different mechanisms of apoptosis resistance observed in interferon-β induced apoptosis of human glioma cells
    • DOI 10.1023/B:NEON.0000024217.68738.11
    • Saito R, Mizuno M, Hatano M, Kumabe T, Yoshimoto T and Yoshida J: Two different mechanisms of apoptosis resistance observed in interferon-β induced apoptosis of human glioma cells. J Neurooncol 67: 273-280, 2004. (Pubitemid 39137357)
    • (2004) Journal of Neuro-Oncology , vol.67 , Issue.3 , pp. 273-280
    • Saito, R.1    Mizuno, M.2    Hatano, M.3    Kumabe, T.4    Yoshimoto, T.5    Yoshida, J.6
  • 5
    • 33947611627 scopus 로고    scopus 로고
    • Perspectives in biomolecular therapeutic intervention in cancer: From the early to the new strategies with type I interferons
    • DOI 10.2174/092986707780059616
    • Vannucchi S, Chiantore MV, Mangino G, Percario ZA, Affabris E, Fiorucci G and Romeo G: Perspective in biomolecular therapeutic intervention in cancer: from the early to the new strategies with type 1 interferons. Curr Med Chem 14: 667-679, 2007. (Pubitemid 46477719)
    • (2007) Current Medicinal Chemistry , vol.14 , Issue.6 , pp. 667-679
    • Vannucchi, S.1    Chiantore, M.V.2    Mangino, G.3    Percario, Z.A.4    Affabris, E.5    Fiorucci, G.6    Romeo, G.7
  • 6
    • 26844476755 scopus 로고    scopus 로고
    • Therapeutic implications of interferon regulatory factor (IRF)-1 and IRF-2 in diffusely infiltrating astrocytomas (DIA): Response to interferon (IFN)-β in glioblastoma cells and prognostic value for DIA
    • DOI 10.1007/s11060-004-7316-1
    • Yoshino A, Katayama Y, Yokoyama T, et al: Therapeutic implication of interferon regulatory factor 1 (IRF-1) and IRF-2 in diffusely infiltrating astrocytomas (DIA): response to IFN-β in glioblastoma cells and prognostic value for DIA. J Neurooncol 74: 249-260, 2005. (Pubitemid 41444490)
    • (2005) Journal of Neuro-Oncology , vol.74 , Issue.3 , pp. 249-260
    • Yoshino, A.1    Katayama, Y.2    Yokoyama, T.3    Watanabe, T.4    Ogino, A.5    Ota, T.6    Komine, C.7    Fukushima, T.8    Kusama, K.9
  • 7
    • 0028345187 scopus 로고
    • Long-term follow-up results of 175 patients with malignant glioma: Importance of radical tumor resection and post-operative adjuvant therapy with interferon, ACNU and radiation
    • Wien
    • Yoshida J, Kajita Y, Wakabayashi T and Sugita K: Long-term follow-up results of 175 patients with malignant glioma: importance of radical tumor resection and post-operative adjuvant therapy with interferon, ACNU and radiation. Acta Neurochir (Wien) 127: 55-59, 1994.
    • (1994) Acta Neurochir , vol.127 , pp. 55-59
    • Yoshida, J.1    Kajita, Y.2    Wakabayashi, T.3    Sugita, K.4
  • 8
    • 0033673643 scopus 로고    scopus 로고
    • Initial and maintenance combination treatment with interferon-β, MCNU (Ranimustine), and radiotherapy for patients with previously untreated malignant glioma
    • Wakabayashi T, Hatano N, Kajita Y, et al: Initial and maintenance combination treatment with interferon-β, MCNU (Ranimustine), and radiotherapy for patients with previously untreated malignant glioma. J Neurooncol 49: 57-62, 2000.
    • (2000) J Neurooncol , vol.49 , pp. 57-62
    • Wakabayashi, T.1    Hatano, N.2    Kajita, Y.3
  • 9
    • 14644399135 scopus 로고    scopus 로고
    • Human interferon beta, nimustine hydrochloride, and radiation therapy in the treatment of newly diagnosed malignant astrocytomas
    • DOI 10.1007/s11060-004-2160-x
    • Watanabe T, Katayama Y, Yoshino A, Fukaya C and Yamamoto T: Human interferon beta, nimustine hydrochloride and radiation therapy in the treatment of newly diagnosed malignant astrocytomas. J Neurooncol 72: 57-62, 2005. (Pubitemid 41149178)
    • (2005) Journal of Neuro-Oncology , vol.72 , Issue.1 , pp. 57-62
    • Watanabe, T.1    Katayama, Y.2    Yoshino, A.3    Fukaya, C.4    Yamamoto, T.5
  • 10
    • 24744452216 scopus 로고    scopus 로고
    • IFN-β down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide
    • DOI 10.1158/0008-5472.CAN-05-0036
    • Natsume A, Ishii D, Wakabayashi T, Tsuno T, Hatano H, Mizuno M and Yoshida J: IFN-β down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide. Cancer Res 65: 7573-7579, 2005. (Pubitemid 41297227)
    • (2005) Cancer Research , vol.65 , Issue.17 , pp. 7573-7579
    • Natsume, A.1    Ishii, D.2    Wakabayashi, T.3    Tsuno, T.4    Hatano, H.5    Mizuno, M.6    Yoshida, J.7
  • 11
    • 39049193568 scopus 로고    scopus 로고
    • Potentiation of antiglioma effect with combined temozolomide and interferon-β
    • Park JA, Joe YA, Kim TG and Hong YK: Potentiation of antiglioma effect with combined temozolomide and interferon-β. Oncol Rep 16: 1253-1260, 2006.
    • (2006) Oncol Rep , vol.16 , pp. 1253-1260
    • Park, J.A.1    Joe, Y.A.2    Kim, T.G.3    Hong, Y.K.4
  • 12
    • 67649419005 scopus 로고    scopus 로고
    • Effect of INF-β on human glioma cell lines with temozolomide resistance
    • Yoshino A, Ogino A, Yachi K, et al: Effect of INF-β on human glioma cell lines with temozolomide resistance. Int J Oncol 35: 139-148, 2008.
    • (2008) Int J Oncol , vol.35 , pp. 139-148
    • Yoshino, A.1    Ogino, A.2    Yachi, K.3
  • 13
    • 54949139977 scopus 로고    scopus 로고
    • A multicenter phase I trial of interferon-β and temozolomide combination therapy for high-grade gliomas (INTEGRA Study)
    • Wakabayashi T, Kayama T, Nishikawa R, et al: A multicenter phase I trial of interferon-β and temozolomide combination therapy for high-grade gliomas (INTEGRA Study). Jap J Clin Oncol 38: 715-718, 2008.
    • (2008) Jap J Clin Oncol , vol.38 , pp. 715-718
    • Wakabayashi, T.1    Kayama, T.2    Nishikawa, R.3
  • 14
    • 0035845531 scopus 로고    scopus 로고
    • Chemosensitivity prediction by transcriptional profiling
    • Staunton JE, Slonim DK, Coller HA, et al: Chemosensitivity prediction by transcriptional profiling. Proc Natl Acad Sci USA 98: 10787-10792, 2001.
    • (2001) Proc Natl Acad Sci USA , vol.98 , pp. 10787-10792
    • Staunton, J.E.1    Slonim, D.K.2    Coller, H.A.3
  • 16
    • 59449085721 scopus 로고    scopus 로고
    • Genomic and molecular profiling predicts response to temozolomide in melanoma
    • Augustine CK, Yoo JS, Potti A, et al: Genomic and molecular profiling predicts response to temozolomide in melanoma. Clin Cancer Res 15: 502-510, 2009.
    • (2009) Clin Cancer Res , vol.15 , pp. 502-510
    • Augustine, C.K.1    Yoo, J.S.2    Potti, A.3
  • 17
    • 0036133902 scopus 로고    scopus 로고
    • Up-regulation of vitamin D3 up-regulated protein 1 gene in response to 5-fluorouracil in colon carcinoma SW620
    • Takahashi Y, Nagata T, Ishii Y, Ikarashi M, Ishikawa K and Asai S: Up-regulation of vitamin D3 up-regulated protein 1 gene in response to 5-fluorouracil in colon carcinoma SW620. Oncol Rep 9: 75-79, 2002.
    • (2002) Oncol Rep , vol.9 , pp. 75-79
    • Takahashi, Y.1    Nagata, T.2    Ishii, Y.3    Ikarashi, M.4    Ishikawa, K.5    Asai, S.6
  • 18
    • 0038206578 scopus 로고    scopus 로고
    • Gene microarrays in hippocampal aging: Statistical profiling identifies novel processes correlated with cognitive impairment
    • Blalock EM, Chen KC, Sharrow K, Herman JP, Porter NM, Foster TC and Landfield PW: Gene microarray in hippocampal aging: statistical profiling identifies novel processes correlated with cognitive impairment. J Neurosci 23: 3807-3819, 2003. (Pubitemid 36958487)
    • (2003) Journal of Neuroscience , vol.23 , Issue.9 , pp. 3807-3819
    • Blalock, E.M.1    Chen, K.-C.2    Sharrow, K.3    Herman, J.P.4    Porter, N.M.5    Foster, T.C.6    Landfield, P.W.7
  • 19
    • 0032754656 scopus 로고    scopus 로고
    • Serum levels of soluble interferon alfa/beta receptor as an inhibitory factor of interferon in the patients with chronic hepatitis C
    • DOI 10.1002/hep.510300516
    • Mizukoshi E, Kaneko S, Kaji K, et al: Serum levels of soluble interferon Alfa/Beta receptor as an inhibitory factor of interferon in the patients with chronic hepatitis C. Hepatology 30: 1325-1331, 1999. (Pubitemid 29510875)
    • (1999) Hepatology , vol.30 , Issue.5 , pp. 1325-1331
    • Mizukoshi, E.1    Kaneko, S.2    Kaji, K.3    Terasaki, S.4    Matsushita, E.5    Muraguchi, M.6    Ohmoto, Y.7    Kobayashi, K.8
  • 21
    • 34347206680 scopus 로고    scopus 로고
    • The human 2′-5′oligoadenylate synthetase family: Unique interferon-inducible enzymes catalyzing 2′-5′ instead of 3′-5′ phosphodiester bond formation
    • DOI 10.1016/j.biochi.2007.02.003, PII S0300908407000302
    • Hovanessian AG and Justesen J: The human 2′-5′oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2′-5′ instead of 3′-5′ phosphodiester bond formation. Biochimie 89: 779-788, 2007. (Pubitemid 47001635)
    • (2007) Biochimie , vol.89 , Issue.6-7 , pp. 779-788
    • Hovanessian, A.G.1    Justesen, J.2
  • 22
    • 33846056843 scopus 로고    scopus 로고
    • Entrez Gene: Gene-centered information at NCBI
    • DOI 10.1093/nar/gkl993
    • Maglott D, Ostell J, Pruitt KD and Tatusova T: Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res 35: D26-D31, 2007. (Pubitemid 46056164)
    • (2007) Nucleic Acids Research , vol.35 , Issue.SUPPL. 1
    • Maglott, D.1    Ostell, J.2    Pruitt, K.D.3    Tatusova, T.4
  • 24
    • 34250205988 scopus 로고    scopus 로고
    • Pharmacogenomics of Type I interferon therapy: A survey of response-modifying genes
    • DOI 10.1016/j.cytogfr.2007.04.012, PII S1359610107000391
    • O'Doherty C, Villoslada P and Vandenbroeck K: Pharmacogenomics of Type I interferon therapy: a survey of response-modifying genes. Cytokine Growth Factor Rev 18: 211-222, 2007. (Pubitemid 46900903)
    • (2007) Cytokine and Growth Factor Reviews , vol.18 , Issue.3-4 , pp. 211-222
    • O'Doherty, C.1    Villoslada, P.2    Vandenbroeck, K.3
  • 25
    • 0020612023 scopus 로고
    • Effect of human leukocyte interferon on malignant brain tumors
    • Hirakawa K, Ueda S, Nakagawa Y, et al: Effect of human leukocyte interferon on malignant brain tumors. Cancer 51: 1976-1981, 1983.
    • (1983) Cancer , vol.51 , pp. 1976-1981
    • Hirakawa, K.1    Ueda, S.2    Nakagawa, Y.3
  • 26
    • 0025063142 scopus 로고
    • A pilot study of recombinant interferon beta (IFN-beta(ser)) in patients with recurrent glioma
    • DOI 10.1007/BF00167065
    • Yung WK, Castellanos AM, Van Tassel P, Moser RP and Marcus SG: A pilot study of recombinant interferon beta (IFN-beta ser) in patients with recurrent glioma. J Neurooncol 9: 29-34, 1990. (Pubitemid 20250792)
    • (1990) Journal of Neuro-Oncology , vol.9 , Issue.1 , pp. 29-34
    • Yung, W.K.A.1    Castellanos, A.M.2    Van Tassel, P.3    Moser, M.R.P.S.G.4
  • 27
    • 34347231940 scopus 로고    scopus 로고
    • Interferon, a growing cytokine family: 50 years of interferon research
    • DOI 10.1016/j.biochi.2007.05.001, PII S0300908407001150
    • Chelbi-Alix MK and Wietzerbin J: Interferon, a growth cytokine family: 50 years of interferon research. Biochimie 89: 713-718, 2007. (Pubitemid 47001648)
    • (2007) Biochimie , vol.89 , Issue.6-7 , pp. 713-718
    • Chelbi-Alix, M.K.1    Wietzerbin, J.2
  • 29
    • 51849086880 scopus 로고    scopus 로고
    • PTEN: A new guardian of the genome
    • Yin Y and Shen WH: PTEN: a new guardian of the genome. Oncogene 27: 5443-5453, 2008.
    • (2008) Oncogene , vol.27 , pp. 5443-5453
    • Yin, Y.1    Shen, W.H.2
  • 30
    • 0032431028 scopus 로고    scopus 로고
    • PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells
    • Li DM and Sun H: PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc Natl Acad Sci USA 95: 15406-15411, 1998.
    • (1998) Proc Natl Acad Sci USA , vol.95 , pp. 15406-15411
    • Li, D.M.1    Sun, H.2
  • 31
    • 0032486198 scopus 로고    scopus 로고
    • Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN
    • DOI 10.1126/science.280.5369.1614
    • Tamura M, Gu J, Matsumoto K, Aota S, Parsons R and Yamada KM: Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280: 1614-1617, 1998. (Pubitemid 28277707)
    • (1998) Science , vol.280 , Issue.5369 , pp. 1614-1617
    • Tamura, M.1    Gu, J.2    Matsumoto, K.3    Aota, S.-I.4    Parsons, R.5    Yamada, K.M.6
  • 32
    • 0035253607 scopus 로고    scopus 로고
    • PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3- kinase/Akt-dependent and -independent pathways
    • Weng L, Brown J and Eng C: PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways. Hum Mol Genet 10: 237-242, 2001. (Pubitemid 32123982)
    • (2001) Human Molecular Genetics , vol.10 , Issue.3 , pp. 237-242
    • Weng, L.-P.1    Brown, J.L.2    Eng, C.3
  • 33
    • 0037439684 scopus 로고    scopus 로고
    • 1in MCF-7 cells
    • Ginn-Pease ME and Eng C: Increased nuclear phophatase and tensin homologue deleted on chromose 10 is associated with G0-G1 in MCF-7 cells. Cancer Res 63: 282-286, 2003. (Pubitemid 36152480)
    • (2003) Cancer Research , vol.63 , Issue.2 , pp. 282-286
    • Ginn-Pease, M.E.1    Eng, C.2
  • 35
    • 0036710512 scopus 로고    scopus 로고
    • The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network
    • DOI 10.1016/S0968-0004(02)02166-7, PII S0968000402021667
    • Mayo LD and Donner DB: The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network. Trends Biochem Sci 27: 462-467, 2002. (Pubitemid 35246255)
    • (2002) Trends in Biochemical Sciences , vol.27 , Issue.9 , pp. 462-467
    • Mayo, L.D.1    Donner, D.B.2
  • 36
    • 0041450058 scopus 로고    scopus 로고
    • PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms
    • Freeman DJ, Li AG, Wei G, et al: PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer Cell 3: 117-130, 2003.
    • (2003) Cancer Cell , vol.3 , pp. 117-130
    • Freeman, D.J.1    Li, A.G.2    Wei, G.3
  • 38
    • 34347338785 scopus 로고    scopus 로고
    • Diverse functions of RNase L and implications in pathology
    • DOI 10.1016/j.biochi.2007.02.006, PII S0300908407000338
    • Bisbal C and Silverman RH: Diverse functions of RNase L and implications in pathology. Biochimie 89: 789-798, 2007. (Pubitemid 47008946)
    • (2007) Biochimie , vol.89 , Issue.6-7 , pp. 789-798
    • Bisbal, C.1    Silverman, R.H.2
  • 40
    • 34347225099 scopus 로고    scopus 로고
    • The dsRNA protein kinase PKR: Virus and cell control
    • DOI 10.1016/j.biochi.2007.03.001, PII S030090840700051X
    • García MA, Meurs EF and Esteban M: The dsRNA protein kinase PKR: virus and cell control. Biochimie 89: 799-811, 2007. (Pubitemid 47001637)
    • (2007) Biochimie , vol.89 , Issue.6-7 , pp. 799-811
    • Garcia, M.A.1    Meurs, E.F.2    Esteban, M.3
  • 42
    • 75749113779 scopus 로고    scopus 로고
    • Effect of WT1 gene silencing on the tumorigenicity of human glioblastoma multiforme cells
    • Clark AJ, Ware JL, Chen MY, et al: Effect of WT1 gene silencing on the tumorigenicity of human glioblastoma multiforme cells. J Neurosurg 112: 18-25, 2010.
    • (2010) J Neurosurg , vol.112 , pp. 18-25
    • Clark, A.J.1    Ware, J.L.2    Chen, M.Y.3
  • 43
    • 77950647838 scopus 로고    scopus 로고
    • Therapeutic potential of Janus-activated kinase-2 inhibitors for the management of myelofibrosis
    • Verstovsek S: Therapeutic potential of Janus-activated kinase-2 inhibitors for the management of myelofibrosis. Clin Cancer Res 16: 1988-1996, 2010.
    • (2010) Clin Cancer Res , vol.16 , pp. 1988-1996
    • Verstovsek, S.1
  • 46
    • 58149144782 scopus 로고    scopus 로고
    • Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators
    • Lo HW, Cao X, Zhu H and Ali-Osman F: Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators. Clin Cancer Res 14: 6042-6054, 2008.
    • (2008) Clin Cancer Res , vol.14 , pp. 6042-6054
    • Lo, H.W.1    Cao, X.2    Zhu, H.3    Ali-Osman, F.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.